AbbVie Inc. (NYSE: ABBV) last traded at $264.96, up 1.20% on the session. The quote above updates while this page is open; the figures below are drawn from AbbVie Inc.’s own filings and are restated only when a new one is published.
AbbVie Inc. trades on NYSE under the ticker ABBV. It is classified in the Healthcare sector, Pharmaceuticals industry. Its market capitalisation is $468.22 billion.
Healthcare sectorPharmaceuticalsListed on NYSE
Valuation measures for AbbVie Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $468.22B |
|---|---|
| P/E ratio | 74.85 |
| Price / sales | 7.27 |
| Beta | -0.08 |
Trailing-twelve-month figures tagged in AbbVie Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $64.39B |
|---|---|
| Net income (TTM) | $6.31B |
| EPS (TTM) | $3.54 |
| Operating margin | 26.20% |
| Cash | $6.57B |
Range and volume for ABBV over the past 52 weeks.
| 52-week high | $267.47 |
|---|---|
| 52-week low | $190.75 |
| Volume | 5.14M |
| Average volume | 6.67M |
| Previous close | $261.83 |
Dividend history for AbbVie Inc. over the trailing twelve months.
| Dividend yield | 2.58% |
|---|---|
| Dividend per share (TTM) | $6.83 |
| Payout ratio | 192.94% |
Other Healthcare companies tracked on FurlPay Markets.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.